Китайское исследование на практике. Простой переход к здоровому образу жизни - Томас Кэмпбелл

Owen M. Herbicide-resistant weeds in genetically engineered crops: Statement before the Subcommittee on Domestic Policy, Committee on Oversight and Government Reform, US House of Representatives, July 28, 2010.

264

Domingo J. L., Gine Bordonaba J. A literature review on the safety assessment of genetically modified plants // Environment International, 2011. Vol. 37. Pp. 734–742.

265

Seralini G. E., Cellier D., de Vendomois J. S. New analysis of a rat feeding study with a genetically modified maize reveals signs of hepatorenal toxicity // Archives of Environmental Contamination and Toxicology, 2007. Vol. 52. Pp. 596–602.

266

deVenomois J. S., Roullier F., Cellier D., Seralini G. E. A comparison of the effects of three GM corn varieties on mammalian health // International Journal of Biological Sciences, 2009. Vol. 5. Pp. 706–726.

267

Snell C., Bernheim A., Berge J. B. et al. Assessment of the health impact of GM plant diets in long-term and multigenerational animal feeding trials: A literature review // Food and Chemical Toxicology, 2012. Vol. 50. Pp. 1134–1148.

268

Seralini G. E., Clair E., Mesnage R. et al. Long-term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize // Food and Chemical Toxicology, 2012. Vol. 50. Pp. 4221–4231.

269

Seralini G. E., Mesnage R., Defarge N. et al. Answers to critics: Why there is a long-term toxicity due to a Roundup-tolerant genetically modified maize and to a Roundup herbicide // Food and Chemical Toxicology, 2013. Vol. 53. Pp. 476–483.

270

Editors. Do Seed Companies Control GM Crop Research? Scientific American, July 20, 2009 // www.scientificamerican.com/article.cfm?id=do-seed-companies-control-gm-crop-research [editorial].

271

Robinson C., Latham J. The Goodman affair: Monsanto targets the heart of science // Independent Science News, May 20, 2013 // www.independentsciencenews.org/sciencemedia/the-goodman-affair-monsanto-targets-the-heart-of-science.

272

Bailey R. L., Gahche J. J., Miller P. E. et al. Why US adults use dietary supplements // JAMA Internal Medicine, 2013. Vol. 173. Pp. 355–361.

273

Marik P. E., Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: A systematic review // Clinical Cardiology, 2009. Vol. 32. Pp. 365–372.

274

Kwak S. M., Myung S. K., Lee Y. J., Seo H. G. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebocontrolled trials // Archives of Internal Medicine, 2012. Vol. 172. Pp. 686–694.

275

Rizos E. C., Ntzani E. E., Bika E. et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis // The Journal of the American Medical Association, 2012. Vol. 308. Pp. 1024–1033.

276

Munro I. A., Garg M. L. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults // Obesity Research and Clinical Practice, 2013. Vol. 7. Pp. e173–e181.

277

Mozurkewich E. L., Clinton C. M., Chilimigras J. L. et al. The Mothers, Omega-3, and Mental Health Study: A double-blind, randomized controlled trial // American Journal of Obstetrics and Gynecology, 2013. Vol. 208. Pp. 313.e1–313.e9.

278

Barbadoro P., Annino I., Ponzio E. et al. Fish oil supplementation reduces cortisol basal levels and perceived stress: A randomized, placebo-controlled trial in abstinent alcoholics // Molecular Nutrition and Food Research, 2013. Vol. 57. Pp. 1110–1114.

279

Sydenham E., Dangour A. D., Lim W. S. Omega 3 fatty acid for the prevention of cognitive decline and dementia // Cochrane Database of Systematic Reviews, 2012. Vol. 6. CD005379.

280

Harris W. S. n-3 Fatty acids and serum lipoproteins: Human studies // American Journal of Clinical Nutrition, 1997. Vol. 65. Pp. 1645S–1654S.

281

Harris W. S., Ginsberg H. N., Arunakul N. et al. Safety and efficacy of Omacor in severe hypertriglyceridemia // Journal of Cardiovascular Risk, 1997. Vol. 4. Pp. 385–391.

282

Pownall H. J., Brauchi D., Kilinc C. et al. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins // Atherosclerosis, 1999. Vol. 143. Pp. 285–297.

283

Lee M. W., Park J. K., Hong J. W. et al. Beneficial effects of omega-3 fatty acids on low density lipoprotein particle size in patients with type 2 diabetes already under statin therapy // Diabetes and Metabolism Journal, 2013. Vol. 37. Pp. 207–211.

284

Rosenson R. Approach to the patient with hypertriglyceridemia. UpToDate.com, January 24, 2014 // www.uptodate.com/contents/approach-to-the-patient-with-hypertriglyceridemia.

285

Ginsberg H. N., Elam M. B., Lovato L. C. et al. Effects of combination lipid therapy in type 2 diabetes mellitus // New England Journal of Medicine, 2010. Vol. 362. Pp. 1563–1574.

286

Esselstyn C. B. Jr., Ellis S. G., Medendorp S. V., Crowe T. D. A strategy to arrest and reverse coronary artery disease: A 5-year longitudinal study of a single physician’s practice // Journal of Family Practice, 1995. Vol. 41. Pp. 560–568.

287

National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/mineral supplements and chronic disease prevention // American Journal of Clinical Nutrition, 2007. Vol. 85. Pp. 257S–264S.

288

Honarbakhsh S., Schachter M. Vitamins and cardiovascular disease // British Journal of Nutrition, 2009. Vol. 101. Pp. 1113–1131.

289

Office of Dietary Supplements, National Institutes of Health. Multivitamin/mineral supplements: Fact sheet for health professionals. January 7, 2013 // ods.od.nih.gov/pdf/factsheets/MVMS-HealthProfessional.pdf.

290

Albanes D., Heinonen O. P., Huttunen J. K. et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study // American Journal of Clinical Nutrition, 1995. Vol. 62. Pp. 1427S–1430S.

291

Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 // Archives of Ophthalmology, 2001. Vol. 119. Pp. 1417–1436.

292

Chew E. Y., Clemons T. E., Agron E. et al. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 // Ophthalmology, 2013. Vol. 120. Pp. 1604–11.e4.

293

Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 // Archives of Ophthalmology, 2001. Vol. 119. Pp. 1439–1452.

294

Bronstein A. C., Spyker D. A., Cantilena L. R. Jr et al. 2008 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th annual report // Clinical Toxicology (Philadelphia), 2009. Vol. 47. Pp. 911–1084.

295

Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academies Press, 2001.

296

Uusi-Rasi K., Karkkainen M. U., Lamberg-Allardt C. J. Calcium intake in health maintenance — A systematic review // Food and Nutrition Research, 2013. Vol. 57. P. 21082.

297

Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011.

298

Moyer V. A. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement // Annals of Internal Medicine, 2013. Vol. 158. Pp. 691–696.

299

Bolland M. J., Avenell A., Baron J. A. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis // BMJ, 2010. Vol. 341. Pp. c3691.

300

Appleby P., Roddam A., Allen N., Key T. Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford // European Journal of Clinical Nutrition, 2007. Vol. 61. Pp. 1400–1406.

301

Sellmeyer D. E., Stone K. L., Sebastian A., Cummings S. R. A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Study of Osteoporotic Fractures Research Group // American Journal of Clinical Nutrition, 2001. Vol. 73. Pp. 118–122.

302

Howe T. E., Shea B., Dawson L. J. et al. Exercise for preventing and treating osteoporosis in postmenopausal women // Cochrane Database of Systematic Reviews, 2011: CD000333.

303

Office of Dietary Supplements, National Institutes of Health. Vitamin D: Fact sheet for health professionals. June 24, 2011 // ods.od.nih.gov/pdf/factsheets/VitaminD-HealthProfessional.pdf.

304

Holick M. F., Binkley N. C., Bischoff-Ferrari H. A. et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited // Journal of Clinical Endocrinology and Metabolism, 2012. Vol. 97. Pp. 1153–1158.

305

Holick M. F. Vitamin D deficiency // New England Journal of Medicine, 2007. Vol. 357. Pp. 266–281.

306

Misra M., Pacaud D., Petryk A. et al. Vitamin D deficiency in children and its management: Review of current knowledge and recommendations // Pediatrics, 2008. Vol. 122. Pp. 398–417.

307

Specker B. L., Valanis B., Hertzberg V. et al. Sunshine exposure and serum 25-hydroxyvitamin D concentrations in exclusively breast-fed infants // Journal of Pediatrics, 1985. Vol. 107. Pp. 372–376.

308

Watanabe F., Yabuta Y., Tanioka Y., Bito T. Biologically active vitamin B12 compounds in foods for preventing deficiency among vegetarians and elderly subjects // Journal of Agricultural and Food Chemistry, 2013. Vol. 61. Pp. 6769–6775.

309

Stabler S. P. Vitamin B12 deficiency // New England Journal of Medicine, 2013. Vol. 368. Pp. 149–160.

310

De Rosa A., Rossi F., Lieto M. et al. Subacute combined degeneration of the spinal cord in a vegan // Clinical Neurology and Neurosurgery, 2012. Vol. 114. Pp. 1000–1002.

311

Brocadello F., Levedianos G., Piccione F. et al. Irreversible subacute sclerotic combined degeneration of the spinal cord in a vegan subject // Nutrition, 2007. Vol. 23. Pp. 622–624.

312

Campbell M., Lofters W. S., Gibbs W. N. Rastafarianism and the vegans syndrome // British Medical Journal, 1982. Vol. 285. Pp. 1617–1618.

313

Kwok T., Lee J., Lam L., Woo J. Vitamin B12 supplementation did not improve cognition but reduced delirium in demented patients with vitamin B12 deficiency // Archives of Gerontology and Geriatrics, 2008. Vol. 46. Pp. 273–282.

314

Oh R., Brown D. L. Vitamin B12 deficiency // American Family Physician, 2003. Vol. 67. Pp. 979–986.

315

Lindenbaum J., Healton E. B., Savage D. G. et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis // New England Journal of Medicine, 1988. Vol. 318. Pp. 1720–1728.